Weight regain and cardiometabolic effects after withdrawal of semaglutide : the STEP 1 trial extension

Source
Diabetes, obesity & metabolism - ISSN 1462-8902-24:8 (2022) p. 1553-1564
Author(s)
    John P.H. Wilding, Rachel L. Batterham, Melanie Davies, Luc Van Gaal, Kristian Kandler, Katerina Konakli, Ildiko Lingvay, Barbara M. McGowan, Tugce Kalayci Oral, Julio Rosenstock, Thomas A. Wadden, Sean Wharton, Koutaro Yokote, Robert F. Kushner

Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes

Source
Diabetes, obesity & metabolism - ISSN 1462-8902-24:5 (2022) p. 788-805